Sompraz%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520hp

# Sompraz HP ## Overview Sompraz HP is a combination product containing pantoprazole, amoxicillin, and clarithromycin. Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid. Amoxicillin and clarithromycin are antibiotics used to eradicate *Helicobacter pylori* (*H. pylori*). ## Primary Indications * Treatment of *Helicobacter pylori* infection in patients with peptic ulcer disease. ## Adult Dosing * Each pack typically contains 14 days of medication. * **Morning dose:** 1 pantoprazole 40 mg delayed-release tablet. * **Morning dose:** 2 amoxicillin 500 mg capsules. * **Morning dose:** 1 clarithromycin 250 mg tablet. * **Evening dose:** 1 pantoprazole 40 mg delayed-release tablet. * **Evening dose:** 2 amoxicillin 500 mg capsules. * **Evening dose:** 1 clarithromycin 250 mg tablet. * **Total daily dose:** Pantoprazole 80 mg, Amoxicillin 2000 mg, Clarithromycin 500 mg. * Duration of therapy is typically 14 days. ## Pediatric Dosing * Dosing for Sompraz HP (or its individual components for *H. pylori* eradication) in pediatric patients is not well-established and should be determined by a specialist based on patient weight and clinical status. ## Dose Adjustments * **Hepatic impairment:** Use with caution. Consider dose reduction of pantoprazole if clinically indicated. Clarithromycin dose may need adjustment in severe hepatic impairment. * **Renal impairment:** Amoxicillin dose may need adjustment in severe renal impairment (CrCl < 30 mL/min). Clarithromycin dose adjustment is typically not required for mild to moderate renal impairment. Pantoprazole generally does not require dose adjustment. ## Contraindications * Hypersensitivity to pantoprazole, amoxicillin, clarithromycin, other macrolides, or penicillins. * History of hypersensitivity to any component of the formulation. * Concomitant use with certain medications (see Key Drug Interactions). * Severe hepatic impairment (pantoprazole). * History of cholestatic jaundice/hepatic dysfunction associated with prior clarithromycin use. ## Adverse Effects * **Common:** Diarrhea, nausea, abdominal pain, headache, rash, taste disturbances. * **Serious:** *Clostridium difficile*-associated diarrhea, severe hypersensitivity reactions (anaphylaxis), Stevens-Johnson syndrome, toxic epidermal necrolysis, hepatic dysfunction, QT prolongation (clarithromycin), anaphylactic reactions (penicillins), *H. pylori* resistance. ## Key Drug Interactions * **Pantoprazole:** Can decrease the absorption of drugs requiring an acidic environment (e.g., ketoconazole, itraconazole, iron salts, vitamin B12). May affect absorption of antiretrovirals. * **Clarithromycin:** Potent inhibitor of CYP3A4. Can increase serum concentrations of drugs metabolized by CYP3A4 (e.g., warfarin, carbamazepine, phenytoin, lovastatin, simvastatin, cisapride, pimozide, amiodarone, certain calcium channel blockers). May increase the risk of rhabdomyolysis with statins. Avoid use with colchicine in renal or hepatic impairment. * **Amoxicillin:** May decrease the efficacy of oral contraceptives. Probenecid may increase and prolong serum levels of amoxicillin. ## Monitoring * Monitor for signs and symptoms of hypersensitivity reactions. * Monitor for signs and symptoms of *Clostridium difficile*-associated diarrhea. * Evaluate *H. pylori* eradication status 4-6 weeks after completion of therapy using urea breath test, stool antigen test, or biopsy. * Monitor liver function tests, especially with prolonged clarithromycin use or in patients with pre-existing hepatic disease. * Assess renal function, particularly in patients with known renal impairment or those receiving other nephrotoxic drugs. ## Clinical Pearls * Ensure patients are not allergic to penicillins or macrolides before initiating therapy. * Instruct patients to complete the full course of therapy, even if symptoms improve. * Pantoprazole should be taken at least 30 minutes before a meal. * Consider *H. pylori* resistance patterns in the local area when choosing empiric therapy. * This combination therapy is one of several options for *H. pylori* eradication. --- *Disclaimer: This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for definitive patient care decisions. Dosing and recommendations may vary based on individual patient factors and local protocols.*